Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zherui Xing

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|September 4, 2023
Retinoic acid-inducible gene-I like receptor pathway in cancer: modification and treatmentGuangyuan Du, Zherui Xing, Jue Zhou, et al.
Translational Lung Cancer Research|October 24, 2025
Multi-omics and Mendelian randomization identify <i>S1PR5</i> as a causal protective gene and NK cell-mediated prognostic biomarker in lung adenocarcinomaZherui Xing, Yuanxin Liu, Xue Yang, et al.
International Journal of Surgery (London, England)|May 28, 2025
Comparative effectiveness for early-stage NSCLC without lymph node involvement based on prospective studiesXue Yang, Zherui Xing, Sirui Long, et al.
Signal Transduction and Targeted Therapy|May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programmingLaiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|September 4, 2023
Retinoic acid-inducible gene-I like receptor pathway in cancer: modification and treatmentGuangyuan Du, Zherui Xing, Jue Zhou, et al.
Translational Lung Cancer Research|October 24, 2025
Multi-omics and Mendelian randomization identify <i>S1PR5</i> as a causal protective gene and NK cell-mediated prognostic biomarker in lung adenocarcinomaZherui Xing, Yuanxin Liu, Xue Yang, et al.
International Journal of Surgery (London, England)|May 28, 2025
Comparative effectiveness for early-stage NSCLC without lymph node involvement based on prospective studiesXue Yang, Zherui Xing, Sirui Long, et al.
Signal Transduction and Targeted Therapy|May 6, 2026
Low-dose radiotherapy synergizes with PD-1 blockade to achieve durable survival in advanced NSCLC through antitumor neutrophil programmingLaiyan Zhou, Yuanxin Liu, Zherui Xing, et al.
Pageof 1